These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35178693)

  • 1. [Psychosis in an adolescent girl treated with sertraline].
    De Proost A; de Meulenaere J
    Tijdschr Psychiatr; 2022; 64(1):43-47. PubMed ID: 35178693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Violent parasomnia associated with a selective serotonin reuptake inhibitor: a case report.
    Khawaja IS; Hurwitz TD; Schenck CH
    J Clin Psychiatry; 2008 Dec; 69(12):1982-3. PubMed ID: 19203482
    [No Abstract]   [Full Text] [Related]  

  • 3. Adolescent angst or true intent? Suicidal behavior, risk, and neurobiological mechanisms in depressed children and teenagers taking antidepressants.
    Morrison J; Schwartz TL
    Int J Emerg Ment Health; 2014; 16(1):247-50. PubMed ID: 25345238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evidence-based review of the clinical use of sertraline in mood and anxiety disorders.
    Sheehan DV; Kamijima K
    Int Clin Psychopharmacol; 2009 Mar; 24(2):43-60. PubMed ID: 21456103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sertraline-induced serotonin syndrome followed by mirtazapine reaction.
    Butler MC; Di Battista M; Warden M
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1128-9. PubMed ID: 20430060
    [No Abstract]   [Full Text] [Related]  

  • 6. Sertraline-associated hair loss.
    Ghanizadeh A
    J Drugs Dermatol; 2008 Jul; 7(7):693-4. PubMed ID: 18664165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Torin (sertraline) in the treatment of depressive and obsessive-compulsive disorders in children].
    Malinina EV; Zabozlaeva IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(8):22-4. PubMed ID: 20823825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyponatremia associated with sertraline and fluoxetine: a case report.
    Raphael K; Tokeshi J
    Hawaii Med J; 2002 Mar; 61(3):46-7. PubMed ID: 11965835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial.
    Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G
    Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder.
    Mathews M; Mathews M; Mathews J
    JAMA; 2004 Jan; 291(1):40; author reply 42. PubMed ID: 14709567
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder.
    Price D
    JAMA; 2004 Jan; 291(1):40-1; author reply 42. PubMed ID: 14709568
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder.
    Solyom AE
    JAMA; 2004 Jan; 291(1):41-2; author reply 42. PubMed ID: 14709569
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder.
    Spielmans GI
    JAMA; 2004 Jan; 291(1):41. PubMed ID: 14709570
    [No Abstract]   [Full Text] [Related]  

  • 15. Strategic use of new generation antidepressants for depression: SUN(^_^)D study protocol.
    Furukawa TA; Akechi T; Shimodera S; Yamada M; Miki K; Watanabe N; Inagaki M; Yonemoto N
    Trials; 2011 May; 12():116. PubMed ID: 21569309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials.
    Wagner KD; Ambrosini P; Rynn M; Wohlberg C; Yang R; Greenbaum MS; Childress A; Donnelly C; Deas D;
    JAMA; 2003 Aug; 290(8):1033-41. PubMed ID: 12941675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.
    Sechter D; Troy S; Paternetti S; Boyer P
    Eur Psychiatry; 1999 Mar; 14(1):41-8. PubMed ID: 10572324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin syndrome associated with sertraline monotherapy at therapeutic doses.
    Ozdemir S; Yalug I; Aker AT
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):897-8. PubMed ID: 18077070
    [No Abstract]   [Full Text] [Related]  

  • 19. Should we use antidepressants for the treatment of major depressive disorder in children and adolescents?
    Birmaher B; Brent D
    Braz J Psychiatry; 2005 Jun; 27(2):89-90. PubMed ID: 15962128
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute angle closure glaucoma after sertraline.
    Ho HY; Kam KW; Young AL; Chan LK; Yu EC
    Gen Hosp Psychiatry; 2013; 35(5):575.e1-2. PubMed ID: 23040863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.